Our Companies
NeuroEM
NeuroEM Therapeutics is a medical device company pioneering a non-invasive, wearable technology designed to treat and potentially reverse cognitive decline in Alzheimer's disease. Their FDA-designated Breakthrough Device, the MemorEM™, delivers Transcranial Electromagnetic Treatment using Radio Frequencies (TEMT-RF) to target and disaggregate toxic protein aggregates (beta-amyloid and p-tau) within neurons, aiming to restore cognitive function and halt disease progression.
PigPug
PigPug is a pediatric neurotechnology company developing an AI-powered, wearable EEG headset system to treat ADHD and autism in children through personalized neurofeedback therapy. Their telemedicine platform combines real-time brainwave monitoring with gamified training exercises supervised by neurofeedback trainers, teaching children how to regulate focus and attention while providing parents and clinicians with detailed progress tracking. The system offers a non-invasive, medication-free treatment approach that transforms traditional neurofeedback therapy into an engaging, accessible experience for young patients.
Psyonic
PSYONIC builds the world’s most advanced and accessible bionic hands for humans and robots. Operating at the intersection of brain-computer interfaces, robotics, and AI, they are uniquely positioned to enhance both human and robotic performance. The company’s flagship product, the Ability Hand, is a fast, durable, touch-sensing bionic hand currently delivering next-gen capabilities to 250+ human users and 50+ leading tech organizations, including Google, NASA, and Toyota. Improvements made for human users directly strengthen the robotics applications, and breakthroughs on the robotics side feed back into the human side, creating a reinforcing cycle where each side accelerates the other. This approach positions PSYONIC to lead the future of human-robot interaction.
MadSci
Madison Scientific (MadSci) is a neurotech company developing novel devices for the treatment and monitoring of patients with hydrocephalus and other neurologic conditions. Their SmartShunt™ Hydrocephalus Management System includes an implantable device that integrates a proprietary valve with advanced sensor technology to continuously monitor and regulate intracranial pressure. The system aims to reduce diagnostic uncertainty and the high failure and complication rates associated with existing shunt technology, representing a paradigm shift that has the potential to improve long-term outcomes and quality of life for a growing patient population.